CN103798792B - A kind of health care biologic product - Google Patents
A kind of health care biologic product Download PDFInfo
- Publication number
- CN103798792B CN103798792B CN201310724784.8A CN201310724784A CN103798792B CN 103798792 B CN103798792 B CN 103798792B CN 201310724784 A CN201310724784 A CN 201310724784A CN 103798792 B CN103798792 B CN 103798792B
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- biologic product
- health care
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036541 health Effects 0.000 title claims abstract description 29
- 235000003365 Ilex pubescens Nutrition 0.000 claims abstract description 16
- 241001100932 Ilex pubescens Species 0.000 claims abstract description 16
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 16
- 235000019713 millet Nutrition 0.000 claims abstract description 16
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 108010023197 Streptokinase Proteins 0.000 claims abstract description 14
- 229960005202 streptokinase Drugs 0.000 claims abstract description 14
- 241000601164 Clematis orientalis Species 0.000 claims abstract description 13
- 241000244987 Daiswa polyphylla Species 0.000 claims abstract description 13
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 13
- 241000018646 Pinus brutia Species 0.000 claims abstract description 13
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 13
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 3
- 241000219063 Rheum rhabarbarum [NCBITaxon:3621] Species 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 abstract description 21
- 201000004810 Vascular dementia Diseases 0.000 abstract description 14
- 210000005013 brain tissue Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 13
- 238000002360 preparation method Methods 0.000 abstract description 13
- 206010008118 cerebral infarction Diseases 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract description 7
- 210000004204 blood vessel Anatomy 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 239000004744 fabric Substances 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 15
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 239000002775 capsule Substances 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 13
- 210000003932 urinary bladder Anatomy 0.000 description 12
- 241000219061 Rheum Species 0.000 description 11
- 210000003414 extremity Anatomy 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000015654 memory Effects 0.000 description 10
- 231100000704 bioconcentration Toxicity 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 238000001093 holography Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000008451 emotion Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010019196 Head injury Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 206010039203 Road traffic accident Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000003164 Diplopia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 208000008348 Post-Concussion Syndrome Diseases 0.000 description 2
- 208000030886 Traumatic Brain injury Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- RMCMHUFPMHONOO-UHFFFAOYSA-N methyl 2-(aminomethyl)benzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=CC=C1CN RMCMHUFPMHONOO-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000004793 poor memory Effects 0.000 description 2
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 208000018726 traumatic encephalopathy Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- BZFBDUQOBQHBSZ-DLCQERRASA-N (3s,8r,9s,10r,13s,14s,17s)-17-[3-(dimethylamino)propyl-methylamino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol;dihydrochloride Chemical compound Cl.Cl.C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](N(C)CCCN(C)C)[C@@]1(C)CC2 BZFBDUQOBQHBSZ-DLCQERRASA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008096 Cerebral atrophy Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000123859 Cyclea racemosa Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000092728 Eleutherococcus gracilistylus Species 0.000 description 1
- 241001489980 Eupolyphaga sinensis Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- -1 carotene carotene Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- LKLWVKCEYSPQHL-KKSFZXQISA-O cyclanoline Chemical compound C12=CC(O)=C(OC)C=C2CC[N@+]2(C)[C@H]1CC1=CC=C(OC)C(O)=C1C2 LKLWVKCEYSPQHL-KKSFZXQISA-O 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- IIQSJHUEZBTSAT-VMPREFPWSA-N fangchinoline Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-VMPREFPWSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000008449 language Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000009251 neurologic dysfunction Effects 0.000 description 1
- 208000015015 neurological dysfunction Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to the field of Chinese medicines, particularly one health care biologic product, also relates to its preparation method.A kind of health care biologic product, bulk drug is containing, for example the Chinese medicine of lower parts by weight: millet 6 ~ 12 parts; 6 ~ 30 parts, pine needle; Ilex pubescens 15 ~ 30 parts; Paris polyphylla 3 ~ 10 parts; 3 ~ 6 parts, pseudo-ginseng; Notopterygium root 8 ~ 12 parts; Cortex acanthopanacis 2 ~ 5 parts; The root of fangji 6 ~ 10 parts; 3 ~ 6 parts, the root of Chinese clematis; Rhubarb 3 ~ 7 parts; Ground bettle streptokinase 6 ~ 18 parts.Further, containing also having aconiti preparata,radix 1 ~ 3 part.This health care biologic product is the biologic product with heat-clearing toxin expelling, clearing damp, loose cold, promoting blood circulation and removing blood stasis, clearing and activating the channels and collaterals, logical blood vessel, tonification and purgation in combination effect, is applicable to brain tissue wound, encephalatrophy, vascular dementia, the rehabilitation of cerebral infarction at restoration stage and sub-health population health preserving cloth use.
Description
Technical field
The present invention relates to the field of Chinese medicines, particularly one health care biologic product, also relates to its preparation method.
Background technology
There is doctor with all kinds of to grind the carbon back of value biological for raw material, utilize conventional art or modern biotechnology manufacture, the various form preparations acting on the prevention (health care) of all kinds of physiological signs of human body, treatment and diagnose.Biologic product is under the jurisdiction of biological products, along with the development of social market, current concepts is divided into prevent disease and build up health immunity reach health-care effect health-care preparation and to reach pharmaceutical preparations two class that disease therapy is order effect.
Brain trauma refers to cause due to foreign object, the macroscopic wound in brains portion, generally can cause serious consequence.Brain trauma often causes permanent disfunction in various degree.This depends primarily on infringement is in certain specific region (focal) of brain tissue or the infringement of popularity (dispersivity).The cerebral lesion of zones of different can cause different symptoms, and focal symptom comprises the symptoms such as motion, sensation, speech, vision, abnormal auditory perception.And DD often affects memory, sleeps or causes clouding of consciousness and stupor.
Encephalatrophy refers to because a variety of causes causes brain tissue itself that organic disease occurs and produces a class neuropsychiatric disease of atrophy.Encephalatrophy comprises Cerebral Atrophy in Children, Adult Human Brain atrophy.Common with the elderly.
Vascular dementia (VD) refer to by Ischemic Stroke, hemorrhagic apoplexy and cause memory, cognitive and behavior Deng Nao district Low perfusion cranial vascular disease caused by severe cognitive dysfunction syndrome.
Cerebral infarction is due to cerebral atherosclerosis, blood vessel internal membrane damage makes cerebral artery luminal stenosis, and then local thrombus is formed because of many factors, arteriarctia is increased the weight of or entirely shuts, cause brain tissue ischemia, anoxic, necrosis, cause a kind of cerebrovascular disease of neurological dysfunction.Office's source property neurologic impairment symptom that clinical signs is hemiplegia, hemianesthesia, speech are unclear etc. occurs suddenly, is mainly in the elderly.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of biologic product with heat-clearing toxin expelling, clearing damp, loose cold, defaecation, promoting blood circulation and removing blood stasis, clearing and activating the channels and collaterals, logical vascular effects, is applicable to brain tissue wound, encephalatrophy, vascular dementia, cerebral infarction at restoration stage rehabilitation and sub-health population health preserving cloth and uses.
Technical problem to be solved by this invention is achieved by the following technical programs:
A kind of health care biologic product, bulk drug is made up of the Chinese medicine of following parts by weight: millet 6 ~ 12 parts; 6 ~ 30 parts, pine needle; Ilex pubescens 15 ~ 30 parts; Paris polyphylla 3 ~ 10 parts; 3 ~ 6 parts, pseudo-ginseng; Notopterygium root 8 ~ 12 parts; Cortex acanthopanacis 2 ~ 5 parts; The root of fangji 6 ~ 10 parts; 3 ~ 6 parts, the root of Chinese clematis; Rhubarb 1.5 ~ 5.5 parts; Ground bettle streptokinase 6 ~ 18 parts.
Described health care biologic product is capsule or pill or tablet, for oral administration.
The preparation method of above-mentioned health care biologic product is:
Step 1, get millet, dry and soft pin or fresh pine needle, ilex pubescens, notopterygium root, cortex acanthopanacis, the root of fangji, the root of Chinese clematis add water boil 60 ~ 120 minutes extract, as culture medium after filtration;
Add ground bettle streptokinase in step 2, culture medium, mixing is placed on 50 ~ 53 DEG C of insulating box fermentations 2 ~ 5 days, dries as powder adapted;
Step 3, pseudo-ginseng, Paris polyphylla, rhubarb to be clayed into power, sterilize, dry, be crushed and screened into fine powder, after being mixed with step 2 gained adapted powder, loading in Capsules and be made into capsule, or be made into tablet, or honey is mixed and is made into pill.
Further, described health care biologic product is also containing aconiti preparata,radix 1 ~ 3 part.Formulation is aqua, external application.Its preparation method is:
Step 1, get millet, dry and soft pin or fresh pine needle, ilex pubescens, notopterygium root, cortex acanthopanacis, the root of fangji, the root of Chinese clematis, adding water boils 60 ~ 120 minutes and obtains extract, as culture medium after filtration;
Ground bettle streptokinase is added, pseudo-ginseng, Paris polyphylla, aconiti preparata,radix 1 ~ 3 part in step 2, culture medium; Rhubarb is clayed into power after high-temperature sterilization and is added in culture medium, and mixing is placed on 50 ~ 53 DEG C of insulating boxs fermentations 2 ~ 7 days, obtains aqua.Aqua external application, is applicable to brain tissue wound, encephalatrophy, vascular dementia, cerebral infarction at restoration stage and sub-health population external application and uses.
In the present invention,
millet:the crude fat content average out to 4.28% of millet, higher than rice, wheat flour, close with corn, wherein unrighted acid accounts for 85% of fatty acid total amount, is of value to and prevents artery sclerosis.The aliphatic acid of millet forms primarily of palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid and arachidic acid, wherein can atherosclerosis, can the linoleic acid content of softening blood vessel, round-grained rice kind accounts for the 13.44-78.4% of content of fatty acid, luffing average out to 45.92%, waxy kind is between 66.81-75.05%, luffing average out to 70.93%, namely waxy kind is higher than round-grained rice kind.
The effect of millet: the deficient and middle kidney-nourishing of strengthening the spleen and stomach, help, except thermal detoxification.Control taste abnormal heat, gastric disorder causing nausea is vomitted, quenches one's thirst, had loose bowels.
pine needle:containing dry 94.04% in pine needle, protein 11.39%, fat 10.31%, ether extract (comprising resin, volatile oil, chlorophyll, carrotene etc.) 11.87%, tannin 4.58%, reduzate 3.36%, pentosan 6.78%, lignin 22.96%, cellulose 29.73%, flooding extract 18.66%, ash content 3.08%, calcic 0.54%, phosphorous 0.08%.In addition to the aforementioned ingredients, also containing a large amount of vitamin, in 3 years raw needles, ascorbic content is 0.522 milligram/gram, carotene carotene content be 0.13-0.2 milligram/gram, chlorophyll be 5-7 milligram/gram.Containing many trace elements in pine needle, as copper, manganese, cobalt, iron etc.Owing to containing above-mentioned active ingredient in pine needle, having many uses too of it is general.
Pine needle can be used as medicine, and its needle can be adopted the whole year, and with twelfth month, the person of adopting is best.Dry after adopting, place dry place and namely make Chinese herbal medicine.Its bitter, puckery, warm in nature, there are expelling wind and activating blood flow, improving eyesight, calm the nerves, detoxify, antipruritic effect.
Cure mainly influenza, epidemic meningitis, rheumatic arthritis, traumatic injury, insomnia edema, impetigo mange, pruitus, yctalopia, high blood disease, scurvy, neurasthenia, chronic bronchitis, Thrombocytopenic purpura.External application treating chilblain.
Have the gastrointestinal reaction that a few peoples occur in various degree after taking medicine, main manifestations is for feeling sick, having a stomach upset.Liquid significant reaction after heating and sugaring seasoning reduces.
ilex pubescens:for the root of holly plant ilex pubescens.Mildly bitter flavor is sweet, and property is put down, nontoxic, can be clearing heat and detoxicating, and cool blood falls apart malicious anti-inflammation, is used for the treatment of coronary heart diseases and angina pectoris and the heart just early stage and the cerebrovascular, peripheral vessels thrombotic diseases, all has the curative effect of affirmative.Ilex pubescens also can hemangiectasis promoting blood circulation and removing obstruction in channels, main containing flavonoids, phenolic constituent.Zoopery proves, can increase coronary flow, reduces MCO, has no significant effect mental and physical efforts and heart rate.
Clinical report: 1. apply this product preparation or decoction treatment coronary heart diseases and angina pectoris, obvious effective rate reaches about 50%, most patient treats about 1 month, heart function all has improvement in various degree, serum ornitrol decreases, blood pressure has decline to a certain degree, also has certain curative effect to cardiac arrhythmia; 2. by this product decoction treatment cerebral thrombus, the loose stasis of blood can be dredged, thus improve blood supply (oxygen) situation of brain tissue; 3. treat thromboangiitis, ilex pubescens, apart from outside hemangiectasis, the effect of stimulating circulation, also has certain antibacterial and anti-inflammation functions to the surface of a wound infected.
ground beetle:(EupolyphagasinensisWalker), commodity soil unit by name, has another name called ground bettle, dustpan worm.Just have about its medicinal record in the Compendium of Material Medica of Ming Dynasty's Li Shizhen (1518-1593 A.D.), it is traditional blood-activating stasis-removing kind insect medicine.Soil unit is cold in nature, taste is salty, micro-poison.Effective in cure to arthritis, traumatic injury, and to leukaemia and cancer all effective in cure.Ground bettle is traditional Chinese medicine activating blood circulation and dispersing blood clots and treat wound.Begin to be loaded in Shennong's Herbal, there is effect of broken trace blood, continuous muscles and bones.Bibliographical information and pharmacological evaluation show, ground bettle n-hexane and n-butyl alcohol extract have certain analgesic activity; N-hexane extract has inhibitory action also to D-galactosamine hepatopathy.The present invention's ground bettle streptokinase used is commercial goods.
paris polyphylla: be the rhizome of liliaceous plant Yunnan Rhizoma Paridis ParisyunnanensisFranch..Cold nature, bitter; Slightly poisonous.Clearing heat and detoxicating, swelling and pain relieving, cool liver arresting convulsion.
pseudo-ginseng:have another name called pseudo-ginseng, belong to Araliaceae Panax herbaceos perennial, be Chinese distinctive rare traditional Chinese medicine, one of Ye Shi China medicinal and edible plant the earliest, can stop blooding, the loose stasis of blood, detumescence, analgesic therapy.
notopterygium root:be Umbelliferae, Notopterygium plant, warming kidney and enhancing yang, receives gas, antidiarrheal.
cortex acanthopanacis:for the root skin of the drying of Araliaceae machaka acanthopanax gracilistylus.There is wines used as antirheumatic, filling liver kidney, the effects such as strengthening the bones and muscles.
the root of fangji:containing multiple alkaloid, be wherein mainly Tet (hanfangchin A Tetrandrine), demethyltetrandrine (hanfangchin B Demethyltetrandrine), Cyclea racemosa Oliv quaternary ammonium base (Cyclanoline) etc.[function cures mainly] inducing diuresis for removing edema, wind-expelling pain-stopping.For oedema beriberi, difficult urination, eczema sore, arthralgia due to wind-dampness; Vascular hypertension.
the root of Chinese clematis:dispel rheumatism, remove obstruction in channels to relieve pain, dissolving phlegm water, the loose hypochondriac lump, cure mainly the stupid numbness of gout, arthralgia due to wind-dampness, extremity numbness, knee crymodynia, the contraction of muscle arteries and veins, joint stuffiness, beriberi, malaria, a lump in the abdomen causing distension and pain, lockjaw, tonsillitis, all bone sticking pharynxs.(1) wines used as antirheumatic pain relieving: for rheumatalgia.Its property benefaction, can pass through.
rhubarb:hardship, cold in nature; Gui Jing: stomach, large intestine, liver, the spleen channel; Effect: attack stagnant, clearing away damp-heat, purging intense heat, cool blood, silt of dispelling, removing toxic substances.
Aconiti preparata,radix is the Preparation process product of monkshood.Pungent, bitter, heat; Poisonous.Dispel rheumatism, antalgic.For wind-cold-dampness arthralgia, breast pain, chest pain with distension sensation, arthralgia, trusted subordinate's crymodynia, cold hernia is had a pain, narcotic analgesic.
The present invention has following beneficial effect:
Biologic product of the present invention by millet, pine needle, ilex pubescens, Paris polyphylla, pseudo-ginseng, notopterygium root, cortex acanthopanacis, the root of fangji, the root of Chinese clematis, rhubarb, ground bettle streptokinase as raw material, and fermentation forms through a couple of days, there is effect of heat-clearing toxin expelling, clearing damp, loose cold, defaecation, promoting blood circulation and removing blood stasis, clearing and activating the channels and collaterals, logical blood vessel.The capsule of preparation, pill, tablet are used for for oral administration, then add aconiti preparata,radix and be prepared into aqua external application and use, and are applicable to brain tissue wound, encephalatrophy, vascular dementia, cerebral infarction at restoration stage rehabilitation and sub-health population and use.Innerwear outer treatment combines, and effect is more remarkable.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be described in detail, and embodiment is only the preferred embodiment of the present invention, is not limitation of the invention.
embodiment 1
A kind of biological health-preserving capsule, its raw material is made up of the component of following mass fraction:
Millet 8 parts; 30 parts, fresh pine needle; Ilex pubescens 25 parts; Paris polyphylla 8 parts; 5 parts, pseudo-ginseng; Notopterygium root 10 parts; Cortex acanthopanacis 4 parts; The root of fangji 8 parts; 5 parts, the root of Chinese clematis; Rhubarb 5 parts; Ground bettle streptokinase 12 parts.
The preparation method of this biological health-preserving capsule is:
Step 1, get millet, fresh pine needle, ilex pubescens, notopterygium root, cortex acanthopanacis, the root of fangji, the root of Chinese clematis add water boil 60 ~ 120 minutes extract, as culture medium after filtration;
Add ground bettle streptokinase in step 2, culture medium, mixing is placed on 51 DEG C of insulating boxs and ferments 3 days, dries as powder adapted;
Step 3, pseudo-ginseng, Paris polyphylla, rhubarb to be clayed into power, sterilize, dry, be crushed and screened into fine powder, after being mixed with step 2 gained adapted powder, loading in Capsules and be made into capsule.
embodiment 2
A kind of biological health piller, raw material is made up of the component of following mass fraction:
Millet 6 parts; 10 parts, dry and soft pin; Ilex pubescens 30 parts; Paris polyphylla 4 parts; 3 parts, pseudo-ginseng; Notopterygium root 9 parts; Cortex acanthopanacis 4 parts; The root of fangji 7 parts; 3 parts, the root of Chinese clematis; Rhubarb 4 parts; Ground bettle streptokinase 18 parts.
The preparation method of this biological health piller is:
Step 1, get millet, dry and soft pin, ilex pubescens, notopterygium root, cortex acanthopanacis, the root of fangji, the root of Chinese clematis, adding water boils 90 minutes and obtains extract, as culture medium after filtration;
Add ground bettle streptokinase in step 2, culture medium, pseudo-ginseng, Paris polyphylla, rhubarb are clayed into power after high-temperature sterilization and add in culture medium, and mixing is placed on 51 DEG C of insulating boxs and ferments 6 days, and dry as powder, being mixed with honey is made into biological health piller.
The capsule that above-mentioned two embodiments are prepared from or pill, there is the effect of heat-clearing toxin expelling, clearing damp, loose cold, defaecation, promoting blood circulation and removing blood stasis, clearing and activating the channels and collaterals, logical blood vessel, be applicable to brain tissue wound, vascular dementia, cerebral infarction at restoration stage and sub-health population and take.Be successfully applied to thousands of routine brain tissue wound, vascular dementia, encephalatrophy, the treatment of Cerebral Infarction Patients, all plays significant effect.
Embodiment 3
The biological aqua of a kind of health care, raw material is made up of the component of following mass fraction:
Millet 6 parts; 6 parts, dry and soft pin; Ilex pubescens 15 parts; Paris polyphylla 10 parts; 6 parts, pseudo-ginseng; Notopterygium root 8 parts; Cortex acanthopanacis 3 parts; The root of fangji 10 parts; 6 parts, the root of Chinese clematis; Aconiti preparata,radix 2 parts; Rhubarb 5.5 parts; Ground bettle streptokinase 6 parts.
The preparation method of the biological aqua of this health care is:
Step 1, get millet, dry and soft pin, ilex pubescens, notopterygium root, cortex acanthopanacis, the root of fangji, the root of Chinese clematis, adding water boils 90 minutes and obtains extract, as culture medium after filtration;
Ground bettle streptokinase is added, pseudo-ginseng, Paris polyphylla, aconiti preparata,radix 1 ~ 3 part in step 2, culture medium; Rhubarb is clayed into power after high-temperature sterilization and is added in culture medium, and mixing is placed on 51 DEG C of insulating boxs and ferments 5 days, obtains health care bioconcentration aqua (magma agent).
This concentrate aqueous liquid is scattered paste shape, can be used as external medicinal liquid, and treatment brain tissue wound, vascular dementia, cerebral infarction, be successfully applied to the treatment of thousands of routine brain tissue wound, vascular dementia, encephalatrophy, Cerebral Infarction Patients, all played significant effect.Be exemplified below:
Case 1
Patient Huang, man, 76 years old, veteran cadre, on October 2nd, 2000 examined.Because of giddy, limbs fatigue has sense of heaviness, numb limb inconvenient walking, and feeblemindedness poor memory directive force is poor, can't take care of oneself.Once had no improvement more than arriving certain central hospital's hospitalization moon, can not walk.Come because of respect for the fame.While in hospital looks into electrocardiogram, and x-ray chest radiograph, biochemistry 10, liver function 12 are all normal.TCD shows: 1. 2. bilateral vertebral artery VPV is asymmetric in cerebral arteriovenous malformation, and MRI shows 1. bilateral corona radiata, centrum ovale and basal ganglia region ischemic change.2. encephalatrophy.DD: 1. multiple cerebral infarction 2. vascular dementia.
encephalatrophy.
Through remaining eye holography examine into: after Eight Diagrams wound.Governor vessel and the left urinary bladder channel of foot-Taiyang have multiple silt to hinder point, to above-mentioned silt resistance point, execute the embodiment of the present invention 3 concentrate aqueous liquid, and to be coated on the resistance point that becomes silted up outside then cupping glass at concentrate aqueous liquid and to control, 15 minutes time, every day 1 time, 7 days courses for the treatment of, after 2 courses for the treatment of.Patient is dizzy, obviously alleviates, and two lower limb are comparatively front strong, can stand firm ten minutes, very like.Add the biological health piller of the embodiment of the present invention 2 sooner or later respectively to take 3 and continuously control two months later, aforementioned every positive symptom completely without.Take embodiment 1 more alternately control half a year with embodiment 2 and fully recover, intelligence and memory are improved, and life can be taken care of oneself, can by motorcycle or bicycle go to countryside to go fishing.Follow up a case by regular visits to 10 years without recurrence.
Case 2
Patient Lee, man, 64 years old, people from Huicheng District, Huizhou City.Examined on 08 16th, 1996.Patient before 7 days in Zhuhai daughter family because of giddy, pectoralgia, uncomfortable in chest, palpitaition, breathes hard, and companion god is tired, limbs fatigue, poor memory.On August 23rd, 1996, examine out of admiration for a famous person from Zhuhai.Western medicine diagnose: encephalatrophy.Tcm diagnosis: rear Eight Diagrams wound, heart meridian trauma.Governor vessel and the left urinary bladder channel of foot-Taiyang have multiple silt to hinder point, take the biological health piller of embodiment 2, every day 2 times, and 7 days are dizzy, pectoralgia, and uncomfortable in chest, palpitaition symptom takes a turn for the better, after one month symptom completely without, look into normal ECG, memory improves.Follow up a case by regular visits to 17 years without recurrence, satisfactory effect.
Case 3
Patient Zhang, man, 73 years old, people from Huicheng District, Huizhou City, veteran cadre, was in hospital and leaves hospital on September 2nd, 2005.DD: 1, right outside generate is through paralysis, 2. sequelae for cerebral infraction, encephalatrophy, 3., before prerolandic artery Rolando, traffic section is interrupted.Because of repeatedly dizzy, diplopia, irritated, memory obviously declines, and limbs fatigue, numb inconvenient walking are examined.
Through remaining eye holography examine into: after Eight Diagrams channels and collaterals sick.There is multiple silt to hinder point to governor vessel and the left urinary bladder channel of foot-Taiyang, embodiment 3 bioconcentration aqua is coated to above-mentioned silt resistance point, concentrate aqueous liquid is controlled outside cupping glass, every day 1 time, 15 days courses for the treatment of.The biological health piller of the oral embodiment of the present invention 2 sooner or later respectively takes 3 and continuously controls two weeks.Giddy, diplopia, agitation obviously alleviate two lower limb comparatively before strong, memory is significantly improved, aforementioned every positive symptom completely without, life can be taken care of oneself.Innerwear outer treatment combines Be very effective.
Follow up a case by regular visits to 8 years without recurrence, effectively control encephalatrophy clinical symptoms and worsen, biologic product of the present invention (capsule) piller has repair cell, recovers the function of organ, serves the curative effect of rehabilitation.
Case 4
Multitude patient, man, 23 years old, people from Huicheng District, Huizhou, student, because traffic accident is in hospital, on November 2nd, 2008 left hospital.DD: 1, the right Nie's Skull defect of craniocerebral trauma, 2. post-traumatic brain syndrome.Patient is because of traffic accident head injury, and senseless more than 10 days, doctor advised family members abandoned treatment, and its aunt younger sister Li Lian be unwilling to.Rear successful rescue, becomes serious brain traumatism sequelae, and dizzy, property function, emotion, language, the disappearances such as memory, weak, the numb inconvenient walking of left limb, aconuresis, can't take care of oneself.Nao Ke hospital conclusion is lost with emotive function brain tissue because brain is managerial, therefore property function, and emotion cannot repair eternal disappearance.
Through remaining eye holography examine into: after Eight Diagrams meridian trauma.Brain has extravasated blood, and brain tissue is hindered.Embodiment 3 bioconcentration aqua is coated, soak one hour after concentrate aqueous liquid is controlled outside cupping glass, every day 1 time, 15 days courses for the treatment of according to the corresponding points of holographic state of internal organs principle to brain.The biological health piller of the oral embodiment of the present invention 2 sooner or later respectively takes 3 and continuously controls 3 months.Aforementioned every positive symptom is clearly better, particularly property erection function, and emotion is significantly improved.Follow up a case by regular visits to 4 years stable disease and have further improvement.The external application of the clinical observation embodiment of the present invention 3 bioconcentration aqua, and the biological health-preserving capsule of the embodiment of the present invention 2, have certain curative effect to the reparation of nerve fiber, and innerwear outer treatment combines Be very effective.
Case 5
Patient Chen, man, 58 years old, civil servant, because of examining as sequelae for cerebral infraction, right side limb adynamia, once arrived certain central hospital and treat more than the moon and have no improvement, on July 5th, 2004 came because of respect for the fame medical.
Examine as: front and back Eight Diagrams channels and collaterals are sick through remaining eye holography.There is multiple silt to hinder point to governor vessel and the left urinary bladder channel of foot-Taiyang, embodiment 3 bioconcentration aqua is coated to above-mentioned silt resistance point, concentrate aqueous liquid is controlled outside cupping glass, every day 1 time, 15 days courses for the treatment of.The biological health piller of the oral embodiment of the present invention 2 sooner or later respectively takes 3 and continuously controls two weeks.Giddy, agitation obviously alleviate two lower limb comparatively before strong, memory is significantly improved, aforementioned every positive symptom completely without, life can be taken care of oneself.Innerwear outer treatment combines Be very effective.
Case 6
Patient thanks certain, and man, 50 years old, civil servant, because of giddy, pain uncomfortable in chest, agitation, memory degradation, be not familiar with lover 3 years, examines as vascular dementia, encephalatrophy, sequelae for cerebral infraction.Once arrived certain central hospital treatment the moon more than have no improvement, on July 5th, 2013 comes because of respect for the fame medical.
Through remaining eye holography examine into: governor vessel and left urinary bladder channel of foot-Taiyang channels and collaterals sick.There is multiple silt to hinder point to governor vessel and the left urinary bladder channel of foot-Taiyang, embodiment 3 bioconcentration aqua is coated to above-mentioned silt resistance point, concentrate aqueous liquid is controlled outside cupping glass, every day 1 time, 15 days courses for the treatment of.The biological health piller of the oral embodiment of the present invention 2 sooner or later respectively takes 3 and continuously controls two weeks.Giddy, it is comparatively front strong that agitation obviously alleviates two lower limb, and memory is significantly improved.Innerwear outer treatment combines Be very effective.
Case 7
Patient Luo, female, 66 years old, cadre, people from Huicheng District, Huizhou City, patient was because of headache, dizzy, and irritated, right side limbs are obviously unable, numb, spiritlessness and weakness, fatiguability, once arrives the diagnosis of certain central hospital: encephalatrophy, has no improvement more than the treatment moon.Tcm diagnosis: rear Eight Diagrams channels and collaterals are sick, gives back governor vessel and left urinary bladder channel of foot-Taiyang silt resistance point coats embodiment 3 bioconcentration aqua, concentrate aqueous liquid is controlled outside cupping glass, every day 1 time, 15 days courses for the treatment of.The biological health piller (capsule) of the oral embodiment of the present invention 2 sooner or later respectively takes 3 and continuously controls two weeks.The biological aqua soak of the external application embodiment of the present invention 3 is continuous controls 30 days, the biological health-preserving capsule of the oral embodiment of the present invention 1 sooner or later respectively take 2 tablets/time 2 times/day totally 25 days, aforementioned every positive symptom completely without.Innerwear outer treatment combines Be very effective.Follow up a case by regular visits to 11 years without recurrence, block encephalatrophy PD.
Case 8
Patient Wu, female, 32 years old, Pinghu, Shenzhen white clay hole people from village, peasant, diagnosis: encephalatrophy.Patient is dizzy, and headache left limb is weak, numb.Once arrived more than certain central hospital treatment moon and had no improvement, on January 8th, 2006, through remaining eye holography examine into: governor vessel and left urinary bladder channel of foot-Taiyang channels and collaterals sick.Give that back governor vessel and the biological aqua soak of the left urinary bladder channel of foot-Taiyang external application embodiment of the present invention 3 are continuous controls 30 days, the biological health-preserving capsule of the oral embodiment of the present invention 1 sooner or later respectively take 2 tablets/time 2 times/day totally 30 days, aforementioned every positive symptom completely without.Innerwear outer treatment combines Be very effective.Follow up a case by regular visits to 13 years without recurrence.
Case 9
Patient Wu, man, 52 years old, cement plant, Longjiang, gantry, Huizhou City workman, because of the diagnosis of traffic accident head injury: post-traumatic brain syndrome.Patient is dizzy, and headache left limb is weak, numb.Once improvement was had no more than arriving certain people's hospitalize moon,
On November 2nd, 2006, through remaining eye holography examine into: after Eight Diagrams channels and collaterals wound.Brain has extravasated blood.According to holographic state of internal organs principle to the corresponding points of brain, pull out that medicinal cupping and the biological aqua soak of the brain external application embodiment of the present invention 3 are continuous controls 30 days, the biological health-preserving capsule of the oral embodiment of the present invention 1 sooner or later respectively take 2 tablets/time 2 times/day totally 25 days, aforementioned every positive symptom is clearly better, particularly property function, emotion is significantly improved.Follow up a case by regular visits to and still make progress for 5 years.The reparation of the biological aqua of the clinical observation embodiment of the present invention 3 to nerve fiber has certain curative effect, and innerwear outer treatment combines Be very effective.
The morbidity origin cause of formation of cerebral infarction, vascular dementia, encephalatrophy shows it is all cause the channels and collaterals of governor vessel and the urinary bladder channel of foot-Taiyang to become silted up with rear Eight Diagrams wound to hinder according to my clinical research, leading to through air-flow of direct obstruction governor vessel and the urinary bladder channel of foot-Taiyang, the few blood of gas is few, blood flow is little slowly, vascular wall is impaired is one of major reason of onset, also be the principle of qi as the commander of blood, blockage of main and collateral channels is then sick, and channels and collaterals general rule is recovered.Clinical study results be channels and collaterals disease formerly, the posterior Pathologic process of angiosis.(Liu is in starting " science and technology China " magazine, 2013,11,12,85; ) above-mentioned cerebral infarction, vascular dementia, encephalatrophy the morbidity origin cause of formation be identical, be all that governor vessel and urinary bladder channel of foot-Taiyang channels and collaterals wound or a variety of causes are obstructed, the cerebrovascular disease sent out by channels and collaterals.According to traditional Chinese medical science treating different diseases with same method principle, take the biological health preparation of the embodiment of the present invention 1 or 2, the embodiment of the present invention 3 bioconcentration aqua, activate blood circulation and disperse blood clots, dredging collateral, logical blood vessel, activating cell, repair cell, recovers organ dysfunction, internal and external application.Wherein, the effect of ground bettle streptokinase is crucial.
Claims (1)
1. keep healthy a biologic product, it is characterized in that bulk drug is made up of the Chinese medicine of following parts by weight: millet 6 ~ 12 parts; 6 ~ 30 parts, pine needle; Ilex pubescens 15 ~ 30 parts; Paris polyphylla 3 ~ 10 parts; Pseudo-ginseng 3 ~ 6 parts; Notopterygium root 8 ~ 12 parts; Cortex acanthopanacis 2 ~ 5 parts; The root of fangji 6 ~ 10 parts; 3 ~ 6 parts, the root of Chinese clematis; Rhubarb 1.5 ~ 5.5 parts; Ground bettle streptokinase 6 ~ 18 parts; Aconiti preparata,radix 1 ~ 3 part,
Described health care biologic product is external application type aqua.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310724784.8A CN103798792B (en) | 2013-12-25 | 2013-12-25 | A kind of health care biologic product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310724784.8A CN103798792B (en) | 2013-12-25 | 2013-12-25 | A kind of health care biologic product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103798792A CN103798792A (en) | 2014-05-21 |
CN103798792B true CN103798792B (en) | 2016-03-30 |
Family
ID=50696563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310724784.8A Active CN103798792B (en) | 2013-12-25 | 2013-12-25 | A kind of health care biologic product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103798792B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104840665A (en) * | 2015-06-19 | 2015-08-19 | 强红枫 | Pharmaceutical composition for preventing and treating acute cerebral blood circulation disturbance and application of pharmaceutical composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317986A (en) * | 2008-07-17 | 2008-12-10 | 洛阳梓生科技开发有限公司 | Method for preparing capsule for dispelling pathogenic wind, removing dampness, removing the obstruction in the channels to relieve pain |
CN102399671A (en) * | 2011-11-18 | 2012-04-04 | 大连得达科技发展有限公司 | Cortex acanthopanacis wine |
CN103005414A (en) * | 2011-09-21 | 2013-04-03 | 王芳 | Blood vessel activation medical porridge and manufacturing method thereof |
-
2013
- 2013-12-25 CN CN201310724784.8A patent/CN103798792B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317986A (en) * | 2008-07-17 | 2008-12-10 | 洛阳梓生科技开发有限公司 | Method for preparing capsule for dispelling pathogenic wind, removing dampness, removing the obstruction in the channels to relieve pain |
CN103005414A (en) * | 2011-09-21 | 2013-04-03 | 王芳 | Blood vessel activation medical porridge and manufacturing method thereof |
CN102399671A (en) * | 2011-11-18 | 2012-04-04 | 大连得达科技发展有限公司 | Cortex acanthopanacis wine |
Non-Patent Citations (1)
Title |
---|
"奚九一治疗动脉硬化闭塞症经验";张建强;《中医杂志》;20040531;第45卷(第5期);第336页的第3-4节 * |
Also Published As
Publication number | Publication date |
---|---|
CN103798792A (en) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104147284B (en) | Chinese herbal preparation for treating epilepsy and preparation method thereof | |
CN109200144A (en) | A kind of Chinese medicine composition and its application and plaster | |
CN104815295A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
CN102727689A (en) | Traditional Chinese herbal composition for treating vertigo, preparation and method for preparing traditional Chinese herbal composition | |
CN108355065A (en) | Plaster and preparation method thereof for treating rheumatism, osteoproliferation and the miscellaneous disease of internal medicine | |
CN101862401B (en) | Chinese medicinal boiled packing bag and method for manufacturing same | |
CN103798792B (en) | A kind of health care biologic product | |
CN104547791A (en) | Traditional Chinese medicine spray for treating low back and leg pain by cooperating with acupuncture and moxibustion and preparation method thereof | |
CN104825956A (en) | Medicine for preventing and treating stroke and recovering muscles, bones and joints | |
CN102872413A (en) | Chinese medicinal composition for treating cervical spondylosis | |
CN103142897B (en) | Medicine used after esophageal achalasia operation | |
CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
CN105126002A (en) | Traditional Chinese medicine preparation for preventing and curing epilepsy and preparation method | |
CN104666799A (en) | Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour | |
CN103585372B (en) | Traditional Chinese medicine preparation for treating cerebral palsy | |
CN101637535B (en) | Medicine for treating bone hyperplasia and preparation method thereof | |
CN105168973A (en) | Traditional Chinese medicine for treating cervical spondylosis and lumbar spondylosis | |
CN104083465A (en) | Medicinal liquor for treating sciatica and lumbar muscle strain and preparation method | |
CN103316248B (en) | Traditional Chinese medicinal preparation for adjuvant therapy of depression and preparation method thereof | |
CN104399053A (en) | Drug for treating schizophrenia and preparation method | |
CN102366584B (en) | Preparation method of traditional Chinese medicinal lotion for treating cold-stagnation bedsore | |
CN103800874A (en) | Medicinal composition for treating extremity function disturbance due to stroke hemiplegia by fumigation therapy | |
CN105535871A (en) | Traditional Chinese medicine plaster for treating cervical muscle type cervical spondylosis | |
CN103638188A (en) | Chinese medicine for preventing and treating chronic osteomyelitis and preparation method thereof | |
CN102406789A (en) | Plaster for treating cervical spondylosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190228 Address after: 516000 Unit C, 4th Building, Riverside Garden, Huicheng District, Huizhou City, Guangdong Province Patentee after: Huizhou Hankang Technology Co., Ltd. Address before: 516001 Huizhou Kemei Medical Instrument Co., Ltd. No. 18 Zhongkai High-tech Development Zone, Huizhou City, Guangdong Province Patentee before: Liu Jiaming |